January 2006
Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2006, p806
Insulin is secreted in response to elevated blood glucose, and its overall effect is to promote glucose use and energy storage. The insulin response test measures the rate of insulin secreted by the beta cells of the islets of Langerhans in the pancreas; it may be performed simultaneously with a 5-hour glucose tolerance test for hypoglycemia.


Related Articles

  • The Lowdown.  // Diabetes Forecast;Jun2014, Vol. 67 Issue 6, p20 

    The article reports on the results of a study which determined that too much insulin can cause severe hypoglycemia or lower blood glucose.

  • Contour Accurately Detects Hypoglycemia. Trecroci, D. // Diabetes Health;Feb/Mar2007, Vol. 16 Issue 1, p56 

    This article reports on a study on the efficacy of the Contour Blood Glucose Meter in detecting hypoglycemia. Under the study, participants were given intravenous insulin in a controlled manner to obtain low blood glucose concentrations. The study concluded that the tool from Bayer accurately...

  • Efficacy of Thrice-daily versus Twice-daily Insulin Regimens on Glycohemoglobin (Hb A1c) in Type 1 Diabetes Mellitus: A Randomized Controlled Trial. Razavi, Zahra; Ahmadi, Mehran // Oman Medical Journal;Jan2011, Vol. 26 Issue 1, p10 

    Objectives: To improve glycemic control and prevent late complications, the patient and diabetes team need to adjust insulin therapy. The aim of this study is to evaluate the efficacy of thrice-daily versus twice-daily insulin regimens on HbA1c for type 1 diabetes mellitus by a randomized...

  • Hypoglycemia in venlafaxine overdose: a hypothesis of increased glucose uptake. Brvar, Miran; Koželj, Gordana; Mašič, Lucija // European Journal of Clinical Pharmacology;Feb2015, Vol. 71 Issue 2, p261 

    The article presents two case studies of patients with a history of depression who were diagnosed with severe hypoglycemia after an overdose of the antidepressant medication venlafaxine. A discussion of diagnostic testing which was conducted on the patients, and found that the hypoglycemia was...

  • Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes. Logtenberg, Susan J.; Kleefstra, Nanne; Houweling, Sebastiaan T.; Groenier, Klaas H.; Gans, Reinold O.; van Ballegooie, Evert; Bilo, Henk J. // Diabetes Care;Aug2009, Vol. 32 Issue 8, p1372 

    OBJECTIVE -- Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump has been available for the past 25 years. CIPII, with its specific pharmacodynamic properties, may be a viable treatment alternative to improve glycemic control in patients with type 1 diabetes for whom...

  • Development of diabetes after gatifloxacin therapy. Stading, Julie A.; Chock, Alan W. Y.; Skrabal, Maryann Z.; Faulkner, Michele A. // American Journal of Health-System Pharmacy;11/1/2005, Vol. 62 Issue 21, p2293 

    Focuses on the development of diabetes after gatifloxacin therapy. Disturbances of blood glucose; Inclusion of symptomatic hyper- and hypoglycemia; Increase in serum insulin levels; Determination of patient's blood glucose concentration.

  • Cutting insulin to lose weight? BAD IDEA... VERY BAD IDEA.  // Countdown;Spring2002, Vol. 23 Issue 2, p25 

    Reports the effects of controlling blood glucose levels through intensive insulin therapy on diabetes-related complications. Increase rate of hypoglycemia; Rate of weight gain; Risk from obesity.

  • Resources for Mastering Low Blood Sugar. Jacobs, Heather // Diabetes Health;Feb/Mar2008, Vol. 17 Issue 1, p34 

    The article offers tips for diabetics on how to deal with hypoglycemia. A reader, who has been insulin-dependent for over 29 years, details how her husband helps her when she suffers from hypoglycemia. It discusses the symptoms of hypoglycemia and the possible factors that may trigger the...

  • Hypoglycemia. Fowler, Michael J. // Clinical Diabetes;Fall2008, Vol. 26 Issue 4, p170 

    The article discusses the fundamentals of diabetes management, focusing on hypoglycemia as a potential complication to diabetes treatment. It mentions that intensive treatment of diabetes brings the risk of lowering blood glucose levels excessively and causing hypoglycemia. The use of exogenous...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics